bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2018: S A J J M A M F J
2017: D N O S

 
  Other news for:
Breast Neoplasms
Neoplasms
 Resources from HONselect
Earlier Mammograms May Mean Less Need for Aggressive Treatments

By Serena Gordon
HealthDay Reporter

THURSDAY, May 3, 2018 (HealthDay News) -- Much of the debate over when to start having mammograms has focused on lives saved, but new research suggests that early screening might also translate into smaller tumors and less aggressive breast cancer treatments.

"There are multiple benefits of mammography in terms of early detection. Not only do we save lives, but we reduce the likelihood of needing more aggressive treatment," said study author Dr. Elisa Port. She directs the Dubin Breast Center at Mount Sinai and is chief of breast surgery at Mount Sinai Hospital, both in New York City.

Currently, the U.S. Preventive Services Task Force recommends that annual screenings start at age 50 for most women, while the American Cancer Society advises that annual screenings begin at age 45. Earlier guidelines had suggested annual screenings begin at age 40.

Port noted that screening guidelines tend to be based on the ability of mammograms to save lives and how often they give a false positive result.

"But isn't there some benefit to getting tested earlier, like needing fewer lymph nodes removed and not needing chemotherapy? I think it's safe to say that most women, if they could be assured the same survival, would choose not to get more aggressive therapies," she said.

Port's study included more than 1,100 women diagnosed with breast cancer at the Dubin Breast Center. All of the women were older than 40.

The women were separated into two groups. One group had a mammogram within the 24 months before their breast cancer diagnosis. The other group had a screening 25 months or more before their diagnosis. The second group also included women who had never had a mammogram.

Women in the second group were 50 percent more likely to need chemotherapy. They were also 32 percent more likely to need surgery to remove the whole breast (mastectomy), and 66 percent more likely to need lymph nodes removed. And the women who were screened earlier had smaller tumors.

Port also looked at the 40- to 49-year-old age group, and found those who had never had a mammogram were much more likely to need chemotherapy. They were also more likely to have larger tumors (by 10 millimeters, on average) and to need a mastectomy than those in the 24 months or less group. But only 29 women fell into the "never had a mammogram" group.

However, the study did not prove a cause-and-effect link between earlier mammograms and smaller tumors and less aggressive treatment.

And Dr. Len Lichtenfeld, deputy chief medical officer for the American Cancer Society, noted that this was an observational study that only looked at the experience of one institution.

Still, "the observations are consistent with what we have seen with the value of early detection. Clearly, the earlier a breast cancer is diagnosed, the less treatment that will be required. But this study doesn't tell us about long-term outcomes or what transpired over a long period of time," he said.

Also, because of the nature of the study and the small sample size in the young age group sub-analysis, Lichtenfeld said that "this cannot be interpreted as a study telling us what age to start mammograms."

The study is to be presented Thursday at the American Society of Breast Surgeons meeting, in Orlando, Fla. Findings presented at meetings are typically viewed as preliminary until published in a peer-reviewed journal.

More information

Learn more about mammography screening guidelines from the American Cancer Society.

SOURCES: Elisa Port, M.D., director, Dubin Breast Center at Mount Sinai, and chief, breast surgery, Mount Sinai Hospital, New York City; Len Lichtenfeld, M.D., deputy chief medical officer, American Cancer Society; May 3, 2018 presentation, American Society of Breast Surgeons meeting, Orlando, Fla.

Copyright © 2018 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=733522

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Neoplasms
Breast
Therapeutics
Women
Mass Screening
Breast Neoplasms
Drug Therapy
Enzyme-Linked Immunosorbent Assay
Mastectomy
Mammography
Diagnosis
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact